Study evaluates the use of tirzepatide in overweight/obese adults with type 1 diabetes

The Eu­ro­pean Com­mis­sion on Thurs­day an­nounced a first for its reg­u­la­tion of the phar­ma in­dus­try: It’s fin­ing five phar­ma com­pa­nies — Al­ka­loids of Aus­tralia, Al­ka­loids

The FDA on Fri­day is­sued two si­mul­ta­ne­ous cys­tic fi­bro­sis ap­provals for Ver­tex Phar­ma­ceu­ti­cals but in­clud­ed high-lev­el safe­ty warn­ings for both. The first ap­proval is for

In the DREAMM-3 trial, belantamab mafodotin (belamaf; Blenrep) did not improve progression-free survival (PFS) in patients with relapsed/refractory multiple myeloma when compared with pomalidomide (Pomalyst)